Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when STI files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Restatement (new) — Company announced restatement of 2024 annual and interim financials due to derivative accounting error.
Solidion restates 2024 financials for $5.7M derivative accounting error
Filed March 24, 2026 · Period ending March 18, 2026 · ~1 min read
Key Changes
-
high
Company invalidated all 2024 audited financials and quarterly reports due to warrant accounting error; investors should not rely on any prior 2024 earnings releases or investor communications until restated financials are filed.
Item 4.02 verify on EDGAR → -
high
Error understated non-cash losses by $5.7M for full year 2024 ($2.3M in Q3, $0.1M in Q2) related to Series A and B warrant exercises; does not affect cash, liquidity, or total stockholders' equity.
Item 4.02 verify on EDGAR → -
medium
Company is reviewing accounting treatment of other financial instruments beyond the identified warrant error, suggesting potential for additional adjustments not yet disclosed.
Item 4.02 verify on EDGAR → -
medium
Auditor changed from Deloitte (2024 auditor) to CBIZ CPAs as current independent registered public accounting firm; both firms were consulted on the restatement.
Item 4.02 verify on EDGAR → -
low
Annual stockholder meeting scheduled for June 11, 2026 with April 3, 2026 deadline for stockholder proposals under Rule 14a-8.
Item 5.08 verify on EDGAR →
Summary
Solidion Technology disclosed a material accounting error requiring restatement of its entire 2024 financial year. The company failed to remeasure Series A and B warrants immediately before certain exercise events, understating non-cash losses by $5.7 million for the year.
While management emphasizes this is purely an accounting adjustment with no impact on cash or liquidity, the invalidation of all 2024 financials and related investor communications is significant. The company also revealed an auditor change from Deloitte to CBIZ, though the timing and reason for this switch were not explained.
Retail investors should understand that any investment decisions made based on 2024 financial data are now suspect until restated figures are published in the 2025 Form 10-K. The ongoing review of other financial instruments suggests additional adjustments may surface. Watch for the restated financials and any further disclosures about the scope of accounting issues or internal control weaknesses that allowed this error to reach audited statements.
Section-by-Section Diff
Event · Item 4.02 — Non-Reliance on Previously Issued Financial Statements
Solidion restates 2024 financials for $5.7M derivative accounting error; prior statements should not be relied upon.
Added in current filing · verify on EDGAR →
the Company’s previously issued audited financial statements as of and for the year ended December 31, 2024 and related audit report as well as the interim periods within that year (the “Affected Financial Information”), included in the Company’s Annual Report on Form 10-K for such period, should no longer be relied upon. Similarly, any prior earnings releases and investor communications that included or discussed the Affected Financial Information should no longer be relied upon.
The CFO and Audit Committee concluded that 2024 audited financials and all interim periods should no longer be relied upon. All prior earnings releases and investor communications discussing these financials are also invalidated. The company will file restated financials in its 2025 Form 10-K.
Added in current filing · verify on EDGAR →
the Company identified an error related to the accounting for exercises of the Company’s Series A and Series B warrants, which relates solely to non-cash derivative accounting adjustments and does not affect the Company’s liquidity, cash balances, or total stockholders’ equity. Specifically, the Company determined that even though it appropriately remeasured the Series A and Series B warrants at each reporting date, the fair value of the warrants was not remeasured immediately prior to certain warrant exercise events and the related settlement of those liabilities in equity during fiscal year 2024.
The error involves Series A and Series B warrant accounting. While warrants were remeasured at each reporting date, they were not remeasured immediately before certain exercise events. This is a non-cash accounting issue that does not impact liquidity, cash, or total stockholders' equity.
Added in current filing · verify on EDGAR →
The Company’s management and the Audit Committee have discussed the matters disclosed in this Current Report on Form 8-K pursuant to this Item 4.02 with CBIZ CPAs P.C., the Company’s independent registered public accounting firm, as well as with Deloitte & Touche LLP, the Company’s auditor for the fiscal year ended December 31, 2024.
The disclosure reveals two different auditors: Deloitte audited fiscal 2024, while CBIZ is now the current independent registered public accounting firm. This indicates an auditor change occurred between 2024 and the current filing date.
Event · Item 5.08 — Shareholder Director Nominations
Procedural 8-K filing referencing Item 5.08 shareholder nomination procedures with no substantive disclosure.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Item 5.08 Shareholder Direct Nominations.
To the extent applicable,
The filing invokes Item 5.08, which relates to shareholder direct nominations under SEC Rule 14a-11, but provides no substantive information beyond a placeholder statement. This appears to be a procedural or incomplete filing with no material business impact disclosed.
Event · Item 8.01 — Other Events
Item 8.01 — Other Events filed; see Key Changes for terms.
Show 2 minor / wording changes
Added in current filing · verify on EDGAR →
The board of directors of the Company has scheduled its first annual meeting of stockholders following the effectiveness of the Company’s Amended and Restated Certificate of Incorporation for June 11, 2026 (the “Annual Meeting”).
The company announced its first annual stockholder meeting following the effectiveness of its Amended and Restated Certificate of Incorporation will be held on June 11, 2026. The record date, time and location will be provided in the proxy statement.
Added in current filing · verify on EDGAR →
The Company has set a deadline of April 3, 2026 for the receipt of any stockholder proposals for inclusion in the proxy materials to be distributed in connection with the Annual Meeting pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which the Company believes to be a reasonable time before it expects to begin to print and distribute its proxy materials for the Annual Meeting.
Stockholders wishing to submit proposals for inclusion in the proxy materials under SEC Rule 14a-8 must do so by April 3, 2026. Proposals received after this date will be considered untimely and must be sent to the CFO at the company's Dallas address.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify